Larson SM - Search Results

1

Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatoses.

Larson SM, Carrasquillo JA, Colcher DC, Yokoyama K, Reynolds JC, Bacharach SA, Raubitchek A, Pace L, Finn RD, Rotman M, et al. Larson SM, et al. J Nucl Med. 1991 Sep;32(9):1661-7. J Nucl Med. 1991. PMID: 1880565 Free article.

2

The correct dose: pharmacologically guided end point for anti-growth factor therapy.

Mulshine JL, Shuke N, Daghighian F, Carrasquillo J, Ghosh B, Walsh T, Avis I, Reynolds JC, Cuttitta F, Larson SM. Mulshine JL, et al. Among authors: larson sm. Cancer Res. 1992 May 1;52(9 Suppl):2743s-2746s. Cancer Res. 1992. PMID: 1314137

3

PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma.

Larson SM, Pentlow KS, Volkow ND, Wolf AP, Finn RD, Lambrecht RM, Graham MC, Di Resta G, Bendriem B, Daghighian F, et al. Larson SM, et al. J Nucl Med. 1992 Nov;33(11):2020-3. J Nucl Med. 1992. PMID: 1432165 Free article.

4

In-vivo identification of tumor multidrug resistance with 3H-colchicine [corrected].

Mehta BM, Rosa E, Fissekis JD, Bading JR, Biedler JL, Larson SM. Mehta BM, et al. Among authors: larson sm. J Nucl Med. 1992 Jul;33(7):1373-7. J Nucl Med. 1992. PMID: 1613580 Free article.

5

Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma.

Scott AM, Kostakoglu L, O'Brien JP, Straus DJ, Abdel-Dayem HM, Larson SM. Scott AM, et al. Among authors: larson sm. J Nucl Med. 1992 Jul;33(7):1396-8. J Nucl Med. 1992. PMID: 1613584 Free article.

6

Innovations that influence the pharmacology of monoclonal antibody guided tumor targeting.

Schlom J, Hand PH, Greiner JW, Colcher D, Shrivastav S, Carrasquillo JA, Reynolds JC, Larson SM, Raubitschek A. Schlom J, et al. Among authors: larson sm. Cancer Res. 1990 Feb 1;50(3 Suppl):820s-827s. Cancer Res. 1990. PMID: 1688734 Review.

7

Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma.

Steis RG, Carrasquillo JA, McCabe R, Bookman MA, Reynolds JC, Larson SM, Smith JW 2nd, Clark JW, Dailey V, Del Vecchio S, et al. Steis RG, et al. Among authors: larson sm. J Clin Oncol. 1990 Mar;8(3):476-90. doi: 10.1200/JCO.1990.8.3.476. J Clin Oncol. 1990. PMID: 1689772

8

Differential cellular catabolism of 111In, 90Y and 125I radiolabeled T101 anti-CD5 monoclonal antibody.

Naruki Y, Carrasquillo JA, Reynolds JC, Maloney PJ, Frincke JM, Neumann RD, Larson SM. Naruki Y, et al. Among authors: larson sm. Int J Rad Appl Instrum B. 1990;17(2):201-7. doi: 10.1016/0883-2897(90)90148-t. Int J Rad Appl Instrum B. 1990. PMID: 1692819

9

Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.

Kostakoglu L, Yeh SD, Portlock C, Heelan R, Yao TJ, Niedzwiecki D, Larson SM. Kostakoglu L, et al. Among authors: larson sm. J Nucl Med. 1992 Mar;33(3):345-50. J Nucl Med. 1992. PMID: 1740700 Free article.

10

Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAb): MSKCC experience with mAb 111In-C110.

Divgi CR, McDermott K, Johnson DK, Schnobrich KE, Finn RD, Cohen AM, Larson SM. Divgi CR, et al. Among authors: larson sm. Int J Rad Appl Instrum B. 1991;18(7):705-10. doi: 10.1016/0883-2897(91)90008-9. Int J Rad Appl Instrum B. 1991. PMID: 1787079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters